Frontiers in Clinical Drug Research - Alzheimer Disorders Impact factor 2025

---

The latest impact factor of Frontiers in Clinical Drug Research - Alzheimer Disorders and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

Frontiers in Clinical Drug Research - Alzheimer Disorders: Aim & Scope

Frontiers in Clinical Drug Research - Alzheimer Disorders is a Web of Science indexed journal tha publishes research in the area: Pharmaceutical Science (Q2); Neurology (clinical) (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3).
The ISSN of this journal is 22145168, 24518743.

Impact factor of Frontiers in Clinical Drug Research - Alzheimer Disorders

Journal Title	Frontiers in Clinical Drug Research - Alzheimer Disorders
Impact Factor
SJR	0.423
ISSN	22145168, 24518743
Quartile	Q2

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

Frontiers in Clinical Drug Research - Alzheimer Disorders

ISSN: 22145168, 24518743
Journal Impact:
Journal Scope: Pharmaceutical Science (Q2); Neurology (clinical) (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

ISSN: 22147527, 24518883
Journal Impact:
Journal Scope: Neurology (clinical); Pharmaceutical Science; Pharmacology (medical)

Alzheimer Disease and Associated Disorders

ISSN: 15464156
Journal Impact:
Journal Scope: Clinical Psychology (Q2); Gerontology (Q2); Psychiatry and Mental Health (Q2); Geriatrics and Gerontology (Q3)

ALZHEIMER DISEASE & ASSOCIATED DISORDERS

ISSN: 0893-0341
Journal Impact: 1.8
Journal Scope: Clinical Neurology | Pathology

Frontiers in Clinical Drug Research - Anti Infectives

ISSN: 24523208, 23523212
Journal Impact:
Journal Scope: Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Frontiers in Clinical Drug Research - HIV

ISSN: 23525916, 24680397
Journal Impact:
Journal Scope: Immunology (Q4); Infectious Diseases (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)

Frontiers in Clinical Drug Research - Anti Allergy Agents

ISSN: 22146938, 24523194
Journal Impact:
Journal Scope: Drug Discovery (Q4); Immunology and Allergy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)

Alzheimer’s & Dementia: Translational Research & Clinical Interventions

ISSN: 2352-8737
Journal Impact:
Journal Scope: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system | Medicine: Internal medicine: Special situations and conditions: Geriatrics

Alzheimer's and Dementia: Translational Research and Clinical Interventions

ISSN: 23528737
Journal Impact:
Journal Scope: Neurology (clinical) (Q1); Psychiatry and Mental Health (Q1)

Alzheimer's & Dementia : Translational Research & Clinical Interventions

ISSN: 2352-8737
Journal Impact:
Journal Scope:

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?